The current stock price of HURN is 161.13 USD. In the past month the price increased by 4.88%. In the past year, price increased by 31.2%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VRSK | VERISK ANALYTICS INC | 31.68 | 30.71B | ||
| EFX | EQUIFAX INC | 27.26 | 25.95B | ||
| LDOS | LEIDOS HOLDINGS INC | 16.1 | 23.97B | ||
| ULS | UL SOLUTIONS INC - CLASS A | 50.23 | 17.56B | ||
| TRU | TRANSUNION | 19.66 | 16.08B | ||
| J | JACOBS SOLUTIONS INC | 21.68 | 15.78B | ||
| CACI | CACI INTERNATIONAL INC -CL A | 22.25 | 13.42B | ||
| BAH | BOOZ ALLEN HAMILTON HOLDINGS | 13.17 | 9.95B | ||
| PSN | PARSONS CORP | 25.96 | 8.87B | ||
| AMTM | AMENTUM HOLDINGS INC | 12.26 | 6.17B | ||
| FCN | FTI CONSULTING INC | 18.91 | 5.25B | ||
| KBR | KBR INC | 10.43 | 5.13B |
Huron Consulting Group, Inc. engages in the provision of technology, data, and analytics solutions. The company is headquartered in Chicago, Illinois and currently employs 7,230 full-time employees. The company went IPO on 2004-10-13. The firm operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; and public, children's and critical access hospitals, and non-acute care providers, including physician practices and medical groups; payors; and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations, and other education-related organizations. Its education and research-focused services and products include spanning technology and analytic-related services. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation.
HURON CONSULTING GROUP INC
550 W van Buren St
Chicago ILLINOIS 60607 US
CEO: James H. Roth
Employees: 6405
Phone: 13125838700
Huron Consulting Group, Inc. engages in the provision of technology, data, and analytics solutions. The company is headquartered in Chicago, Illinois and currently employs 7,230 full-time employees. The company went IPO on 2004-10-13. The firm operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; and public, children's and critical access hospitals, and non-acute care providers, including physician practices and medical groups; payors; and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations, and other education-related organizations. Its education and research-focused services and products include spanning technology and analytic-related services. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation.
The current stock price of HURN is 161.13 USD. The price decreased by -1.36% in the last trading session.
HURN does not pay a dividend.
HURN has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
HURON CONSULTING GROUP INC (HURN) currently has 6405 employees.
HURON CONSULTING GROUP INC (HURN) has a market capitalization of 2.79B USD. This makes HURN a Mid Cap stock.
HURON CONSULTING GROUP INC (HURN) will report earnings on 2026-02-23, after the market close.
ChartMill assigns a technical rating of 10 / 10 to HURN. When comparing the yearly performance of all stocks, HURN is one of the better performing stocks in the market, outperforming 88.8% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to HURN. While HURN has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months HURN reported a non-GAAP Earnings per Share(EPS) of 7.57. The EPS increased by 28.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.54% | ||
| ROA | 7.02% | ||
| ROE | 21.68% | ||
| Debt/Equity | 1.18 |
11 analysts have analysed HURN and the average price target is 197.63 USD. This implies a price increase of 22.65% is expected in the next year compared to the current price of 161.13.
For the next year, analysts expect an EPS growth of 19.82% and a revenue growth 12.38% for HURN